Venture Capital Investors

Versant Ventures

VC firm Versant Ventures provides capital to promising technology companies.

Venture Investor Overview

Venture Investor
Versant Ventures
Status
Active
Investor Type
Venture Capital
Activity Level
351 transaction
Funds Raised
At least $2.7 billion
Industry Focus
Biopharmaceutical
Healthcare Services

Contact Information

Contact
William Link
Title
Managing Partner
Mailing Address
1 Sansome 3630
San Francisco, CA 94104
USA
Phone
(415) 801-8100
Website
www.versantventures.com
Email Address
Not Recorded

Background Information

Overview
Versant invests in all segments of healthcare including, Medical Devices & Instruments, life sciences, healthcare services and healthcare information technology.
Profile
Versant Ventures LinkedIn Company Profile
Social Media
Versant Ventures Company Twitter Account
Company News
Versant Ventures News
Facebook
Versant Ventures on Facebook
YouTube
Versant Ventures on YouTube
Last Transaction
2/15/2024

Transaction History

Our records indicate that Versant Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Firefly Bio
2/15/2024
$94,000,000
Enterprise Therapeutics
1/30/2024
$32,780,000
Nouscom
11/14/2023
$73,693,000
Gate Bioscience
11/1/2023
$60,000,000
Nexo Therapeutics
7/27/2023
$60,000,000
Kate Therapeutics
6/8/2023
$51,000,000
Abdera Therapeutics
4/20/2023
$142,000,000
Belharra Therapeutics
1/4/2023
$130,000,000
iECURE
11/30/2022
$65,000,000
Jnana Therapeutics
11/15/2022
$107,000,000
Cimeio Therapeutics
4/13/2022
Unknown
Ventus Therapeutics
2/18/2022
$140,000,000
CODA Biotherapeutics
12/6/2021
$28,000,000
Tentarix Biotherapeutics
10/18/2021
$50,000,000
858 Therapeutics
9/23/2021
$60,000,000
iECURE
9/10/2021
$50,000,000
Jnana Therapeutics
8/19/2021
$50,000,000
Turnstone Biologics
7/22/2021
$80,000,000
LENZ Therapeutics
6/23/2021
$47,000,000
LENZ Therapeutics
6/21/2021
$47,000,000
RayzeBio
6/16/2021
$108,000,000
Capsida Biotherapeutics
4/30/2021
$50,000,000
Ventus Therapeutics
4/9/2021
$100,000,000
Graphite Bio
3/16/2021
$150,000,000
Monte Rosa Therapeutics
3/15/2021
$95,000,000
Century Therapeutics
3/4/2021
$160,000,000
Vividion Therapeutics
2/25/2021
$135,000,000
Pipeline Therapeutics
2/12/2021
$80,000,000
RayzeBio
12/9/2020
$105,000,000
RayzeBio
10/15/2020
$45,000,000
Monte Rosa Therapeutics
9/25/2020
$96,000,000
Lava Therapeutics
9/18/2020
$83,000,000
Graphite Bio
9/17/2020
$45,000,000
Chinook Therapeutics
8/20/2020
$106,000,000
Bright Peak Therapeutics
7/30/2020
$35,000,000
Lycia Therapeutics
6/10/2020
$50,000,000
Monte Rosa Therapeutics
5/27/2020
$32,500,000
Ventus Therapeutics
5/7/2020
$60,000,000
Pandion Therapeutics
4/2/2020
$80,000,000
Black Diamond Therapeutics
12/6/2019
$85,000,000
CODA Biotherapeutics
11/7/2019
$15,000,000
Repare Therapeutics
9/5/2019
$82,500,000
Chinook Therapeutics
8/23/2019
$65,000,000
Century Therapeutics
7/2/2019
$250,000,000
Vividion Therapeutics
5/1/2019
$82,000,000
Oyster Point Pharmaceuticals
2/27/2019
$93,000,000
Passage Bio
2/19/2019
$115,500,000
Nuvaira
2/12/2019
$79,000,000
Kinestral Technologies
1/31/2019
$100,000,000
Black Diamond Therapeutics
1/11/2019
$85,000,000
Akero Therapeutics
12/13/2018
$70,000,000
Black Diamond Therapeutics
12/12/2018
$20,000,000
Aprea Therapeutics
12/3/2018
$56,869,550
AlterG
10/9/2018
$6,000,000
CoDa Therapeutics
9/14/2018
$19,000,000
Akero Therapeutics
6/26/2018
$65,000,000
Inari Medical
3/30/2018
$27,000,000
Tempest Therapeutics
3/29/2018
$70,000,000
Crinetics Pharmaceuticals
3/15/2018
$63,500,000
Quentis Therapeutics
2/28/2018
$48,000,000
Pandion Therapeutics
1/19/2018
$58,000,000
Intuity Medical
1/9/2018
$70,000,000
Metavention
1/9/2018
$65,000,000
Jnana Therapeutics
12/16/2017
$50,000,000
Oyster Point Pharmaceuticals
11/8/2017
$22,000,000
Gritstone Oncology
9/8/2017
$92,700,000
Sebacia
7/26/2017
$36,000,000
VenatoRx Pharmaceuticals
7/26/2017
$42,000,000
Repare Therapeutics
6/23/2017
$68,000,000
Monteris Medical
6/2/2017
$26,600,000
Tarveda Therapeutics
2/4/2017
$30,000,000
Vividion Therapeutics
2/3/2017
$50,000,000
Kinestral Technologies
2/1/2017
$65,000,000
TherAchon
1/11/2017
$5,000,000
Intuity Medical
1/6/2017
$15,000,000
Cereve
1/6/2017
$38,000,000
Veran Medical Technologies
12/22/2016
$31,000,000
Intuity Medical
11/11/2016
$40,000,000
Turnstone Biologics
11/3/2016
$41,400,000
Rox Medical
9/7/2016
$40,000,000
Minerva Surgical
3/31/2016
$15,000,000
Kyras Therapeutics
12/14/2015
Unknown
Inception IBD
12/14/2015
$14,100,000
Crinetics Pharmaceuticals
11/3/2015
$40,000,000
Turnstone Biologics
10/29/2015
$11,300,000
Gritstone Oncology
10/21/2015
$102,000,000
Audentes Therapeutics
10/14/2015
$65,000,000
TherAchon
10/1/2015
$35,000,000
Advanced ICU Care
9/30/2015
$7,324,901
ConcertoCare
9/30/2015
$15,250,000
Inception 2
9/30/2015
$2,002,000
Veran Medical Technologies
9/22/2015
$30,600,000
Inari Medical
7/1/2015
$12,400,000
Kinestral Technologies
6/30/2015
$5,937,000
Sebacia
6/25/2015
$22,000,000
NeuWave Medical
5/28/2015
$25,000,000
CRISPR Therapeutics
4/30/2015
$64,000,000
Benvenue Medical
3/31/2015
$13,875,000
Laguna Pharmaceuticals
2/17/2015
$30,000,000
RuiYi
12/31/2014
$5,000,000
Sequent Medical
12/31/2014
$100,000
Audentes Therapeutics
12/3/2014
$42,500,000
AcuFocus
9/4/2014
$21,000,000
Inception 5
6/30/2014
$5,000,000
TWELVE
6/30/2014
$9,076,000
Inception 1
6/30/2014
$5,500,000
Neurotech Pharmaceuticals
6/30/2014
$5,054,000
Benvenue Medical
6/19/2014
$64,000,000
Ceterix Orthopaedics
5/13/2014
$18,000,000
ForSight VISION5
4/16/2014
$15,000,000
Sequent Medical
4/4/2014
$20,000,000
Holaira
4/3/2014
$42,000,000
Cerephex
3/31/2014
$9,820,000
RuiYi
3/27/2014
$15,000,000
Achaogen
12/31/2013
$10,000,000
Celula
12/31/2013
$7,000,000
Inception 4
12/13/2013
$10,000,000
Immune Design
10/30/2013
$49,000,000
Rox Medical
9/30/2013
$2,614,000
Theraclone Sciences
9/30/2013
$4,000,000
Nexis Vision
9/30/2013
$10,020,000
Intersection Medical
9/30/2013
$9,036,000
Audentes Therapeutics
7/19/2013
$30,000,000
Calderome
6/30/2013
$14,950,200
Benvenue Medical
6/30/2013
$10,000,000
Neurotech Pharmaceuticals
6/30/2013
$7,000,000
Helical Solutions
6/30/2013
$2,500,000
Fidelis Seniorcare
6/30/2013
$5,071,200
Veracyte
6/28/2013
$28,000,000
WaveTec Vision Systems
6/24/2013
$11,000,000
ForSight VISION5
6/18/2013
$9,300,000
Novira Therapeutics
3/26/2013
$7,500,000
Theraclone Sciences
3/25/2013
$14,000,000
Holaira
2/11/2013
$10,000,000
Glaukos
2/8/2013
$30,000,000
Ocular Therapeutix
1/28/2013
$23,800,000
Ceterix Orthopaedics
1/22/2013
$19,500,000
Cerephex
12/31/2012
$5,924,000
Minerva Surgical
12/31/2012
$20,000,000
Flexion Therapeutics
12/4/2012
$20,000,000
CardiAQ Valve Technologies
11/29/2012
$37,300,000
Spark Diagnostics
9/30/2012
$500,000
GluMetrics
9/30/2012
$4,000,000
AlterG
9/30/2012
$10,310,000
Newgrounds
9/30/2012
$17,500,000
Intuity Medical
9/30/2012
$12,000,000
Forsight Vision3
9/30/2012
$8,000,000
Inception 2
6/30/2012
$5,000,000
Foundry Newco XII
6/30/2012
$15,000,100
Second Sight Medical Products
6/30/2012
Unknown
Benvenue Medical
6/29/2012
$25,000,000
Zyga Technology
5/17/2012
$25,000,000
WaveTec Vision Systems
4/10/2012
$16,500,000
Holaira
4/6/2012
$10,600,007
Flexion Therapeutics
3/31/2012
$13,000,000
Redbrick Health
3/31/2012
$5,000,100
OpGen
3/7/2012
$17,000,000
Sequent Medical
3/7/2012
$26,000,000
Skylight Healthcare Systems
12/31/2011
$950,100
Rennovia
12/31/2011
$22,333,000
Groove Biopharma
12/12/2011
$6,000,000
AcuFocus
11/30/2011
$65,000,000
Advanced ICU Care
10/11/2011
$8,000,000
Redbrick Health
9/30/2011
$5,000,000
Kythera Biopharmaceuticals
9/15/2011
$37,424,989
Intuity Medical
8/2/2011
$76,000,000
Celula
6/30/2011
$3,000,000
Halscion
6/30/2011
$3,499,900
WaveTec Vision Systems
6/30/2011
$15,920,700
Sebacia
6/30/2011
$5,600,000
Holaira
6/30/2011
$5,000,000
Benvenue Medical
4/18/2011
$35,500,000
Next Therapeutics
3/31/2011
$3,002,000
Redbrick Health
3/31/2011
$5,773,000
Ocular Therapeutix
2/2/2011
$14,000,000
Achaogen
12/31/2010
$20,952,300
Semprae Laboratories
12/30/2010
$6,099,900
OpGen
9/27/2010
$17,000,000
Immune Design
7/26/2010
$32,000,000
Rennovia
6/30/2010
$6,000,000
Veracyte
6/10/2010
$28,000,000
Celula
5/19/2010
$15,000,000
Sequent Medical
5/13/2010
$15,600,000
Groove Biopharma
4/26/2010
Unknown
Achaogen
4/7/2010
$56,000,000
Inogen
3/31/2010
$9,000,000
OraMetrix
12/31/2009
$8,161,000
Neurotech Pharmaceuticals
12/31/2009
$5,700,100
Second Sight Medical Products
12/31/2009
$5,000,000
Advanced ICU Care
12/31/2009
$2,000,000
Clovis Oncology
12/31/2009
$65,635,000
Halscion
12/31/2009
$6,000,000
Metabolex
11/6/2009
$8,600,000
Flexion Therapeutics
10/16/2009
$33,000,000
Kythera Biopharmaceuticals
9/30/2009
$10,000,000
Veracyte
9/30/2009
$10,500,000
Rennovia
9/18/2009
$6,000,000
Novasys Medical
7/21/2009
$18,950,000
Clovis Oncology
6/30/2009
$146,300,000
Forsight Vision3
6/30/2009
$12,000,100
Ocular Therapeutix
6/19/2009
$15,000,000
Redbrick Health
4/1/2009
$15,000,000
Ambrx
4/1/2009
$10,000,000
Inogen
3/31/2009
$3,066,000
LenSx Lasers
3/29/2009
$22,000,000
WaveTec Vision Systems
2/26/2009
$20,100,000
Kythera Biopharmaceuticals
2/18/2009
$10,000,000
AlterG
1/13/2009
$8,000,000
Acclarent
1/12/2009
$26,000,000
RuiYi
1/8/2009
$25,000,000
NewHope Bariatrics
12/31/2008
$6,000,000
HotSpur Technologies
12/31/2008
$1,250,000
CodeRyte
11/14/2008
$13,000,000
Lutonix
10/27/2008
$20,000,000
APT Pharmaceuticals
9/30/2008
$32,000,000
ForteBio
9/24/2008
$25,000,000
Pathwork Diagnostics
9/5/2008
$20,000,000
Microfabrica
9/4/2008
$22,500,000
GluMetrics
8/10/2008
$20,000,080
Palamida
6/30/2008
$5,516,000
OpGen
6/30/2008
$10,384,000
Respira
6/30/2008
Unknown
Five Prime Therapeutics
6/30/2008
$40,282,000
Second Sight Medical Products
6/30/2008
Unknown
Skylight Healthcare Systems
6/30/2008
$750,000
Advanced ICU Care
6/25/2008
$5,000,000
Vaccsys
6/18/2008
$9,000,000
Cameron Health
6/16/2008
$51,500,000
Rox Medical
6/2/2008
$35,000,000
Kythera Biopharmaceuticals
5/19/2008
$40,000,000
Novasys Medical
5/16/2008
$49,500,000
RuiYi
4/15/2008
$8,000,000
Halscion
3/31/2008
$4,500,000
Spiration
3/25/2008
$18,500,000
Trius Therapeutics
3/24/2008
$25,342,000
Cameron Health
3/15/2008
$14,100,000
Calderome
3/10/2008
$11,900,000
Ocular Therapeutix
3/7/2008
$6,000,000
Mode Media
2/25/2008
$84,600,000
Comedy Online
2/22/2008
Unknown
OraMetrix
2/7/2008
$20,000,000
Confirma
1/9/2008
$17,500,000
Benvenue Medical
1/7/2008
$15,000,000
Anza Therapeutics
12/31/2007
$18,000,000
Trius Therapeutics
12/31/2007
$4,658,000
Inogen
12/31/2007
$12,648,000
Antipodean Pharmaceuticals
12/31/2007
$2,980,000
ConcepTx Medical
12/31/2007
$4,000,000
Synosia Therapeutics
12/31/2007
$10,000,000
Redbrick Health
12/19/2007
$15,000,000
APT Pharmaceuticals
10/4/2007
$22,000,000
OraMetrix
9/30/2007
$1,574,000
MeeVee
9/21/2007
$3,500,000
OpGen
9/12/2007
$23,600,000
Vital Therapies
9/12/2007
$28,100,000
OsteoLign
9/10/2007
$10,000,000
Neoconix
7/16/2007
$16,000,000
Calderome
6/30/2007
$1,100,100
Respira
6/30/2007
$3,367,200
Ambrx
6/30/2007
Unknown
NDO Surgical
6/30/2007
$1,999,000
GlobalServe
6/30/2007
$1,500,000
Tensys Medical
6/30/2007
$5,700,000
Five Prime Therapeutics
6/30/2007
Unknown
OraMetrix
6/30/2007
$5,208,000
Redbrick Health
6/30/2007
$500,000
The Innovation Factory
6/27/2007
$7,000,000
WaveTec Vision Systems
5/31/2007
$13,000,000
Acclarent
4/23/2007
$35,000,000
Metabolex
4/19/2007
$32,000,000
ForSight Labs
4/3/2007
$5,000,000
AcuFocus
3/31/2007
$17,999,800
NovaCardia
3/31/2007
$18,000,200
Seredigm
3/31/2007
$2,499,900
Amira Pharmaceuticals
3/23/2007
$25,000,000
Trius Therapeutics
2/27/2007
$20,000,000
Inogen
2/16/2007
$22,000,000
Vantage Oncology
2/9/2007
$22,500,000
Synosia Therapeutics
1/5/2007
$32,500,000
Calderome
12/31/2006
$300,000
Mode Media
12/14/2006
$19,000,000
NeoVista
12/8/2006
$41,000,000
Neurotech Pharmaceuticals
11/16/2006
$35,000,000
Real Girls Media Network
11/16/2006
$6,000,000
NewHope Bariatrics
11/8/2006
$18,500,000
Achaogen
10/10/2006
$26,000,000
Matisse Networks
9/30/2006
$14,000,000
OsteoLign
9/30/2006
$900,000
NovaCardia
9/29/2006
$48,000,000
NeoGuide Systems
9/26/2006
$25,000,000
Inogen
9/21/2006
$9,500,000
Vantage Oncology
8/28/2006
$6,000,000
Kythera Biopharmaceuticals
7/24/2006
$30,000,000
Ambrx
7/5/2006
$52,000,000
Fluidigm
6/30/2006
$4,999,800
Cameron Health
6/30/2006
$31,255,000
Synosia Therapeutics
6/30/2006
$30,000,100
Ambrx
6/30/2006
$28,364,000
Celula
6/30/2006
$6,200,000
Palamida
6/12/2006
$8,000,000
Spiration
4/3/2006
$13,400,000
Cadence Pharmaceuticals
3/31/2006
$53,800,000
Ablation Frontiers
3/31/2006
$15,000,000
Second Sight Medical Products
3/31/2006
Unknown
Jazz Pharmaceuticals
3/31/2006
$35,000,000
Synosia Therapeutics
3/31/2006
$2,499,900
MedManage Systems
3/31/2006
$10,750,000
Ambrx
3/31/2006
$5,000,000
Amira Pharmaceuticals
3/31/2006
$3,999,900
Snocap
3/31/2006
$15,000,000
Helicos BioSciences
3/15/2006
$40,000,000
MeeVee
2/27/2006
$6,500,000
Insulet
2/16/2006
$50,000,000
Transcept Pharmaceuticals
1/4/2006
$25,000,000
Amira Pharmaceuticals
11/28/2005
$6,000,000
Iconoculture
11/2/2005
$10,000,000
H5 Technologies
10/31/2005
$15,000,000
ForteBio
10/26/2005
$17,300,000
Market Insight
10/17/2005
$1,250,000
Antipodean Pharmaceuticals
9/30/2005
$14,550,000
AcuFocus
6/30/2005
$27,500,000
Pathwork Diagnostics
6/30/2005
$10,000,000
Jazz Pharmaceuticals
6/30/2005
$99,999,900
Skylight Healthcare Systems
6/30/2005
$3,999,900
Amphora Discovery
6/30/2005
$9,549,800
Fovi Optics
6/30/2005
$19,700,000
OraMetrix
5/13/2005
$25,000,000
Vantage Oncology
5/10/2005
$22,000,000
Ambrx
4/8/2005
$23,400,000
Theraclone Sciences
3/31/2005
$800,000
BlueLithium
2/28/2005
$11,500,000
Palamida
2/15/2005
$5,000,000
Five Prime Therapeutics
2/8/2005
$45,000,000
Alexza Pharmaceuticals
1/6/2005
$52,000,000
NDO Surgical
12/15/2004
$15,000,000
Amphora Discovery
12/8/2004
$20,000,000
Metabolex
11/30/2004
$44,000,000
Accelerator Alumni
11/18/2004
$11,800,000
Concuity
10/19/2004
$8,300,000
Camero
6/30/2004
$6,000,000
MedManage Systems
4/26/2004
$6,000,000
Jazz Pharmaceuticals
3/24/2004
$250,000,000
ServiceBench
3/4/2004
$3,200,000
Insulet
3/2/2004
$35,500,000
Helicos BioSciences
2/2/2004
$27,000,000
Transcept Pharmaceuticals
1/8/2004
$35,000,000
Spiration
1/6/2004
$26,900,000
Skylight Healthcare Systems
12/22/2003
$8,000,000
NeoGuide Systems
12/12/2003
$14,000,000
Phenomix
10/14/2003
$35,500,000
Five Prime Therapeutics
9/23/2003
$12,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Brian Atwood
  Brian Atwood LinkedIn Profile  Brian Atwood Twitter Account  Brian Atwood News  Brian Atwood on Facebook
Managing Director
Bradley Bolzon
  Bradley Bolzon LinkedIn Profile  Bradley Bolzon Twitter Account  Bradley Bolzon News  Bradley Bolzon on Facebook
Managing Director
Samuel Colella
  Samuel Colella LinkedIn Profile  Samuel Colella Twitter Account  Samuel Colella News  Samuel Colella on Facebook
Managing Director
Jerel Davis
  Jerel Davis LinkedIn Profile  Jerel Davis Twitter Account  Jerel Davis News  Jerel Davis on Facebook
Partner
Gianni Gromo
  Gianni Gromo LinkedIn Profile  Gianni Gromo Twitter Account  Gianni Gromo News  Gianni Gromo on Facebook
Managing Director
Ross Jaffe
  Ross Jaffe LinkedIn Profile  Ross Jaffe Twitter Account  Ross Jaffe News  Ross Jaffe on Facebook
Managing Director
William Link
  William Link LinkedIn Profile  William Link Twitter Account  William Link News  William Link on Facebook
Managing Director
Barbara Lubash
  Barbara Lubash LinkedIn Profile  Barbara Lubash Twitter Account  Barbara Lubash News  Barbara Lubash on Facebook
Partner
Guido Magni
  Guido Magni LinkedIn Profile  Guido Magni Twitter Account  Guido Magni News  Guido Magni on Facebook
Managing Director
Donald Milder
  Donald Milder LinkedIn Profile  Donald Milder Twitter Account  Donald Milder News  Donald Milder on Facebook
Managing Director
Kirk Nielsen
  Kirk Nielsen LinkedIn Profile  Kirk Nielsen Twitter Account  Kirk Nielsen News  Kirk Nielsen on Facebook
Managing Director
Clare Ozawa
  Clare Ozawa LinkedIn Profile  Clare Ozawa Twitter Account  Clare Ozawa News  Clare Ozawa on Facebook
Partner
Carlo Rizzuto
  Carlo Rizzuto LinkedIn Profile  Carlo Rizzuto Twitter Account  Carlo Rizzuto News  Carlo Rizzuto on Facebook
Managing Director
Rebecca Robertson
  Rebecca Robertson LinkedIn Profile  Rebecca Robertson Twitter Account  Rebecca Robertson News  Rebecca Robertson on Facebook
Managing Director
Charles Warden
  Charles Warden LinkedIn Profile  Charles Warden Twitter Account  Charles Warden News  Charles Warden on Facebook
Managing Director
Thomas Woiwode
  Thomas Woiwode LinkedIn Profile  Thomas Woiwode Twitter Account  Thomas Woiwode News  Thomas Woiwode on Facebook

 

Funds

Our database includes the following fund closing(s) for Versant Ventures. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Versant Venture Capital VII
12/17/2018
$600,000,000
Versant Voyageurs I
12/17/2018
$100,000,000
Versant Venture Capital VI
1/4/2017
$400,000,000
Versant Venture Capital V
12/10/2014
$305,000,000
Versant Venture Capital IV
8/1/2008
$500,000,000
Versant Venture Capital III
11/9/2005
$400,000,000
Versant Venture Capital II
6/30/2001
$400,000,000

 

Portfolio Companies

Versant Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
858 Therapeutics
Abdera Therapeutics
Ablation Frontiers
Accelerator Alumni
Acclarent
Achaogen
AcuFocus
Advanced ICU Care
Akero Therapeutics
Alexza Pharmaceuticals
AlterG
Ambrx
Amira Pharmaceuticals
Amphora Discovery
Antipodean Pharmaceuticals
Anza Therapeutics
Aprea Therapeutics
APT Pharmaceuticals
Audentes Therapeutics
Belharra Therapeutics
Benvenue Medical
Black Diamond Therapeutics
BlueLithium
Bright Peak Therapeutics
Cadence Pharmaceuticals
Calderome
Camero
Cameron Health
Capsida Biotherapeutics
CardiAQ Valve Technologies
Celula
Century Therapeutics
Cerephex
Cereve
Ceterix Orthopaedics
Chinook Therapeutics
Cimeio Therapeutics
Clovis Oncology
CODA Biotherapeutics
CoDa Therapeutics
CodeRyte
Comedy Online
ConcepTx Medical
ConcertoCare
Concuity
Confirma
Crinetics Pharmaceuticals
CRISPR Therapeutics
Enterprise Therapeutics
Fidelis Seniorcare
Firefly Bio
Five Prime Therapeutics
Flexion Therapeutics
Fluidigm
ForSight Labs
Forsight Vision3
ForSight VISION5
ForteBio
Foundry Newco XII
Fovi Optics
Gate Bioscience
Glaukos
GlobalServe
GluMetrics
Graphite Bio
Gritstone Oncology
Groove Biopharma
H5 Technologies
Halscion
Helical Solutions
Helicos BioSciences
Holaira
HotSpur Technologies
Iconoculture
iECURE
Immune Design
Inari Medical
Inception 1
Inception 2
Inception 4
Inception 5
Inception IBD
Inogen
Insulet
Intersection Medical
Intuity Medical
Jazz Pharmaceuticals
Jnana Therapeutics
Kate Therapeutics
Kinestral Technologies
Kyras Therapeutics
Kythera Biopharmaceuticals
Laguna Pharmaceuticals
Lava Therapeutics
LenSx Lasers
LENZ Therapeutics
Lutonix
Lycia Therapeutics
Market Insight
Matisse Networks
MedManage Systems
MeeVee
Metabolex
Metavention
Microfabrica
Minerva Surgical
Mode Media
Monte Rosa Therapeutics
Monteris Medical
NDO Surgical
Neoconix
NeoGuide Systems
NeoVista
Neurotech Pharmaceuticals
NeuWave Medical
Newgrounds
NewHope Bariatrics
Nexis Vision
Nexo Therapeutics
Next Therapeutics
Nouscom
NovaCardia
Novasys Medical
Novira Therapeutics
Nuvaira
Ocular Therapeutix
OpGen
OraMetrix
OsteoLign
Oyster Point Pharmaceuticals
Palamida
Pandion Therapeutics
Passage Bio
Pathwork Diagnostics
Phenomix
Pipeline Therapeutics
Quentis Therapeutics
RayzeBio
Real Girls Media Network
Redbrick Health
Rennovia
Repare Therapeutics
Respira
Rox Medical
RuiYi
Sebacia
Second Sight Medical Products
Semprae Laboratories
Sequent Medical
Seredigm
ServiceBench
Skylight Healthcare Systems
Snocap
Spark Diagnostics
Spiration
Synosia Therapeutics
Tarveda Therapeutics
Tempest Therapeutics
Tensys Medical
Tentarix Biotherapeutics
The Innovation Factory
TherAchon
Theraclone Sciences
Transcept Pharmaceuticals
Trius Therapeutics
Turnstone Biologics
TWELVE
Vaccsys
Vantage Oncology
VenatoRx Pharmaceuticals
Ventus Therapeutics
Veracyte
Veran Medical Technologies
Vital Therapies
Vividion Therapeutics
WaveTec Vision Systems
Zyga Technology

 

 

 

 

Browse more venture capital investors:

Verras Capital | Vershina Capital

 

Share this article

 

About Our VC Firm Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.